- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NanoSensors,Inc. (OTC Bulletin Board: NNSR.OB), a nanotechnology development company
that is developing a biosensor to detect e.coli and salmonella announced
today that it has received 85 units of the disposable housing unit and 10
units of the data acquisition unit from its third-party manufacturers.
These units will be used for independent third-party testing.
As previously announced, the Company's biosensor consists of two core
functional parts: a disposable housing unit (Razor Blade) in which the
actual sensor device is mounted and a separate, external data acquisition
unit (Razor). Based on this design, the disposable housing unit which
contains the sensor transmits signals across electrical leads to the data
acquisition unit, which accepts the output signal from the disposable
housing unit and converts the signal to the appropriate format to display
The Company is in the process of functionalizing the sensors that will
be placed inside the disposable housing units. Once the sensors are
functionalized the Company will be able to finalize its testing program and
initiate independent third party testing of the biosensor product. The
Company intends to find a cross-section of potential customers that will
test the product and provide feedback on the functionality.
The Company has also initiated the task of evaluating the process
parameters for the detection of salmonella using its licensed technology.
Consistent with its marketing plan, the Company is working on a development
plan for modifying its biosensor to detect e.coli in order to introduce a
biosensor device for the detection of salmonella in food and water, the
need for which was recently evidenced by the outbreak of salmonella in
"We are extremely satisfied with the production of our first biosensor
prototypes for use in third party testing," stated Dr. Ted Wong, the
Company's Chief Executive Officer. "We are eager to now focus on the
commencement of a test program to assist us in completing product
development and effectively introducing it into the marketplace."
Pictures of the prototypes can be found at http://www.nanosensorsinc.net .
Information contained on our web site is not part of this press release.
NanoSensors, Inc. was incorporated in December 2003 and is a
nanotechnology development company based in Santa Clara, California. The
Company's principal business is the development, manufacturing and
marketing of sensors and instruments to detect biological, chemical and
explosive agents, principally a sensor device to detect e.coli and
salmonella in food and water.
This press release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, and are
subject to the safe harbors created thereby. These forward-looking
statements involve known and unknown risks, uncertainties and other facts
that could cause the actual future results of the Company to be materially
different from such forward looking statements. These forward-looking
statements are made only as of the date hereof, and we disclaim any
obligation to update or revise the information contained in any such
forward-looking statements, whether as a result of new information, future
events or otherwise.
For more information, please click here
1800 Wyatt Drive, Suite #2
Santa Clara , CA 95054
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Tip-assisted chemistry enables chemical reactions at femtoliter scale November 16th, 2016
'Back to the Future' inspires solar nanotech-powered clothing November 15th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016
ANU invention to inspire new night-vision specs December 7th, 2016
Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016